Advisory Opinions On Supplement Ad Claims Infeasible, FTC Finds
This article was originally published in The Tan Sheet
Executive Summary
Providing companies with advisory opinions clarifying Federal Trade Commission positions on "competent and reliable scientific evidence" standards for dietary supplement ad claims may not be feasible due to human resource concerns and previous rulings, the commission states.
You may also be interested in...
FTC Should Send Warning Letters For Potentially Misleading Claims – Petition
The Federal Trade Commission should use warning letters when contested health benefit claims are "at worst, only potentially misleading," according to a petition for rulemaking submitted to FTC April 15
FTC Should Send Warning Letters For Potentially Misleading Claims – Petition
The Federal Trade Commission should use warning letters when contested health benefit claims are "at worst, only potentially misleading," according to a petition for rulemaking submitted to FTC April 15
FTC Should Send Warning Letters For Potentially Misleading Claims – Petition
The Federal Trade Commission should use warning letters when contested health benefit claims are "at worst, only potentially misleading," according to a petition for rulemaking submitted to FTC April 15